Your browser doesn't support javascript.
loading
Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.
Samuel, Priya; Pink, Ryan Charles; Caley, Daniel Paul; Currie, James Michael Stevenson; Brooks, Susan Ann; Carter, David Raul Francisco.
Afiliação
  • Samuel P; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Gipsy Lane, Oxford, OX3 0BP, UK.
  • Pink RC; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Gipsy Lane, Oxford, OX3 0BP, UK.
  • Caley DP; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Gipsy Lane, Oxford, OX3 0BP, UK.
  • Currie JM; Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, V5Z 1L3, Canada.
  • Brooks SA; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Gipsy Lane, Oxford, OX3 0BP, UK.
  • Carter DR; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Gipsy Lane, Oxford, OX3 0BP, UK.
Tumour Biol ; 37(2): 2565-73, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26386726

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Subunidades alfa do Canal de Potássio Ativado por Cálcio de Condutância Alta Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Subunidades alfa do Canal de Potássio Ativado por Cálcio de Condutância Alta Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article